ResMed Inc (ASX: RMD) shares got hammered this last year. Here’s why the ASX 200 healthcare share looks poised for an ...

Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2026 on Thursday, August 6, 2026, after the New York Stock ...

Chime Financial, Inc. (CHYM) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This ...

Shares of medical device company ResMed (NYSE:RMD) jumped 3.7% in the afternoon session after it was added to Goldman Sachs' ...

Please note, Resmed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only. A replay of the earnings webcast will be accessible on ...

Explore how changing treatment trends and industry competition are influencing ResMed’s future outlook, innovation strategy, ...

SAN DIEGO, June 30, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2026 on Thursday, ...

ASX healthcare shares surged 21% over the past month. Can CSL, ResMed, and Cochlear keep climbing into the future?

Shares of ResMed Inc. RMD rallied 1.49% to $191.26 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 1.44% to 7,365.46 and Dow ...

ResMed’s $340 million acquisition of Noctrix Health adds a wearable neuromodulation device for restless legs syndrome to its sleep portfolio. (iStock/Getty Images Plus) ResMed has closed its $340 ...